Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression

Glioblastoma (GBM) is the most frequent malignant glioma. Treatment of GBM patients is multimodal with maximum surgical resection, followed by concurrent radiation and chemotherapy with the alkylating drug temozolomide (TMZ). The present study aims to identify genes implicated in the acquired resist...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Le Calvé, Benjamin, Rynkowski, Michal, Le Mercier, Marie, Bruyère, Céline, Lonez, Caroline, Gras, Thierry, Haibe-Kains, Benjamin, Bontempi, Gianluca, Decaestecker, Christine, Ruysschaert, Jean-Marie, Kiss, Robert, Lefranc, Florence
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press Inc. 2010
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933693/
https://ncbi.nlm.nih.gov/pubmed/20824049
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak